CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug ...
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...
VALLEY COTTAGE, New York, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade ...
BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...
For Vivasure Medical, good things come in twos. In tandem with its announcement this week that the FDA has greenlit a pivotal study of its PerQseal arterial closure device, the Irish devicemaker also ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback